AVD American Vanguard Corp
American Vanguard Corporation is a diversified specialty and agricultural products company that develops and markets products for crop protection and management, turf and ornamentals management and public and animal health. American Vanguard is included on the Russell 2000® and Russell 3000® Indexes and the Standard & Poor’s Small Cap 600 Index. To learn more about American Vanguard, please reference the Company’s web site atwww.american-vanguard.com.
Company profile
Ticker
AVD
Exchange
CEO
Eric Glenn Wintemute
Employees
Incorporated in
Location
Fiscal year end
Industry (SEC)
SEC CIK
Corporate docs
IRS number
952588080
AVD stock data
()
Calendar
7 Aug 19
24 Aug 19
31 Dec 19
News
Company financial data Financial data
| Quarter (USD) | Jun 19 | Mar 19 | Dec 18 | Sep 18 | |
|---|---|---|---|---|---|
| Revenue | 113.1M | 99.68M | 131.34M | 111.78M | |
| Net income | 3.11M | 3.91M | 7.42M | 6.53M | |
| Diluted EPS | 0.11 | 0.13 | 0.25 | 0.22 | |
| Net profit margin | 2.75% | 3.92% | 5.65% | 5.84% | |
| Operating income | 6.29M | 6.9M | 11.38M | 11.67M | |
| Net change in cash | -350K | 489K | -3.2M | 2.27M | |
| Cash on hand | 6.31M | 6.66M | 6.17M | 9.37M | |
| Cost of revenue | 71.45M | 57.97M | 78.36M | 66.48M |
| Annual (USD) | Dec 18 | Dec 17 | Dec 16 | Dec 15 | |
|---|---|---|---|---|---|
| Revenue | 454.27M | 355.05M | 312.11M | 289.38M | |
| Net income | 24.2M | 20.27M | 12.79M | 6.59M | |
| Diluted EPS | 0.81 | 0.68 | 0.44 | 0.23 | |
| Net profit margin | 5.33% | 5.71% | 4.10% | 2.28% | |
| Operating income | 39.02M | 26.79M | 20.54M | 11.52M | |
| Net change in cash | -5.17M | 3.47M | 2.35M | 639K | |
| Cash on hand | 6.17M | 11.34M | 7.87M | 5.52M | |
| Cost of revenue | 271.64M | 207.66M | 183.83M | 177.48M |
Financial data from company earnings reports
Financial report summary
?Management Discussion
- Following is a more detailed discussion of our sales performance by category. Domestic sales finished the year at $300,314, as compared to $256,142 in 2017, an increase of 17%. Sales gains resulted from strong growth in our US cotton defoliant Folex®, increased sales of our soil fumigant products in light of more favorable weather conditions, as compared to the prior year and full-year sales of products (paraquat, abamectin and chlorothalonil) and businesses (OHP) acquired in 2017. These gains were offset by softness in the procurement of our corn soil insecticides (as growers shifted significant acreage to soybeans in 2018), a decrease in sales of our Thimet® granular soil insecticide (due to a 20% reduction in peanut acres in 2018), a decline in sales of our mosquito adulticide Dibrom (from the exceptional hurricane-driven demand of 2017), and a reduction in our toll manufacturing business, which will be shifted into 2019.
Content analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
abnormally, absorption, aerial, aided, allegedly, Arroz, assumption, banning, bifenthrin, bispyribac, breakup, burn, carcinogenicity, closer, cold, concept, contrary, delayed, diflubenzuron, distributor, drought, equivalent, etoxazole, event, evidence, expedited, explanation, fee, glyphosate, guarantee, inclement, insufficient, integrated, intended, legislation, local, Maryland, mentioned, modest, negatively, overview, pace, passed, passing, past, persistent, precipitation, purported, put, Raymat, registered, rendered, replenished, row, Science, scientific, sector, sodium, solid, Stifle, strategic, trend, unable, valid, warrant, York
Removed:
achieved, adversely, arose, Costa, decline, depend, financing, fourth, fungicide, interview, provision, Rica
Financial reports
10-Q
2019 Q2
Quarterly report
7 Aug 19
10-Q
2019 Q1
Quarterly report
8 May 19
10-K
2018 FY
Annual report
12 Mar 19
10-Q
2018 Q3
Quarterly report
6 Nov 18
10-Q
2018 Q2
Quarterly report
6 Aug 18
10-Q
2018 Q1
Quarterly report
8 May 18
10-K
2017 FY
Annual report
14 Mar 18
10-Q
2017 Q3
Quarterly report
2 Nov 17
10-Q
2017 Q2
Quarterly report
31 Jul 17
10-Q
2017 Q1
Quarterly report
4 May 17
Current reports
8-K
American Vanguard Reports Second Quarter Andmid-year 2019 Results
7 Aug 19
8-K
Results of Operations and Financial Condition
24 Jul 19
8-K
American Vanguard Announces Voting Results
11 Jun 19
8-K
Regulation FD Disclosure
5 Jun 19
8-K
American Vanguard Reports First Quarter 2019 Results
8 May 19
8-K
Other Events
2 Apr 19
8-K
American Vanguard Reports Fourth Quarter & Full Year 2018 Results
12 Mar 19
8-K
American Vanguard Acquires Brazilian Agricultural Distributor
11 Jan 19
8-K
Acquired products are complementary to major herbicide tolerant crop systems
4 Jan 19
8-K
American Vanguard Declares Quarterly Dividend
11 Dec 18
Registration and prospectus
8-A12B
Registration of securities on exchange
28 Feb 06
424B5
Prospectus supplement for primary offering
9 Feb 06
S-8
Registration of securities for employees
15 Jun 05
S-3
Shelf registration
25 Feb 05
S-3/A
Shelf registration (amended)
28 Apr 04
S-3/A
Shelf registration (amended)
28 Jan 04
S-3
Shelf registration
30 Sep 03
S-8
Registration of securities for employees
7 Jan 03
S-8
Registration of securities for employees
2 Jan 02
S-8
Registration of securities for employees
29 Jun 01
Proxies
DEFA14A
Additional proxy soliciting materials
22 Apr 19
DEF 14A
Definitive proxy
22 Apr 19
DEF 14A
Definitive proxy
23 Apr 18
DEF 14A
Definitive proxy
21 Apr 17
DEFA14A
Additional proxy soliciting materials
21 Apr 17
DEF 14A
Definitive proxy
25 Apr 16
DEFA14A
Additional proxy soliciting materials
25 Apr 16
DEF 14A
Definitive proxy
23 Apr 15
DEF 14A
Definitive proxy
23 Apr 14
DEF 14A
Definitive proxy
23 Apr 13
Other
UPLOAD
Letter from SEC
15 May 13
CORRESP
Correspondence with SEC
19 Apr 13
UPLOAD
Letter from SEC
19 Mar 13
CORRESP
Correspondence with SEC
18 Jan 13
CORRESP
Correspondence with SEC
13 Dec 12
UPLOAD
Letter from SEC
12 Dec 12
UPLOAD
Letter from SEC
16 Aug 10
CORRESP
Correspondence with SEC
5 Aug 10
UPLOAD
Letter from SEC
2 Jul 10
CT ORDER
Confidential treatment order
17 Mar 09